Characterisation of an anti-glycan monoclonal antibody against ovarian cancer
Ovarian cancer is a deadly disease that has been associated with changes in glycans. Therefore, anti-glycan monoclonal antibodies (mAb) have the potential to selectively kill or retard chemoresistant tumours. However, the interactions between mAb and glycan epitopes are difficult to characterise due...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2016
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.745230 |